Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity

BACKGROUND: Design, results, and interpretation of oncology randomised controlled trials (RCTs) have changed substantially over the past decade. In this study, we describe all RCTs evaluating anticancer therapies in haematological cancers published globally during 2014–2017 with comparisons with sol...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengar, Manju, Hopman, Wilma M, Mohyuddin, Ghulam Rehman, Goodman, Aaron M, Gyawali, Bishal, Mukherji, Deborah, Hammad, Nazik, Pramesh, CS, Aggarwal, Ajay, Sullivan, Richard, Booth, Christopher M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310333/
https://www.ncbi.nlm.nih.gov/pubmed/37396096
http://dx.doi.org/10.3332/ecancer.2023.1558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310333/
https://www.ncbi.nlm.nih.gov/pubmed/37396096
http://dx.doi.org/10.3332/ecancer.2023.1558

Ejemplares similares